Foundayo

The Foundayo price shown during ordering is the best starting point for comparing total cost. Because dosing follows a fixed step-up schedule — not a menu of interchangeable strengths — look at where you are in that schedule rather than assuming a lower strength number means a lower price. Total monthly cost should be compared on a like-for-like basis: strength, quantity, and total tablets supplied together, not a single number pulled out of context.

If you are reviewing cost without insurance, focus on the cash-pay total for the strength and quantity your plan calls for. Do not change strength or skip a scheduled dose increase based on price alone — ask your clinician first, since the step-up schedule exists to reduce gastrointestinal side effects, not just to reach a target dose.

CDI is a prescription referral service — we do not dispense, manufacture, prescribe, or ship medications ourselves. We connect you with licensed healthcare providers and independent third-party pharmacies, where legally permitted. All prescribing, dispensing, and delivery is handled by those parties.

• Choose the correct medicine: confirm you are ordering Foundayo (orforglipron tablets), not an injectable GLP-1 medication or a different oral GLP-1 product such as Rybelsus or Wegovy Pill.
• Match the strength to your clinician’s current directions — 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, or 17.2 mg — depending on where you are in the step-up schedule.
• Confirm quantity (30 tablets per pack).
• Take Foundayo once daily, any time of day, with or without food or water — do not double up if a dose is missed without checking your clinician’s guidance first.
• Tell your care team about all other medications, especially oral hormonal contraceptives, since Foundayo can slow how other oral drugs are absorbed.

Foundayo is indicated, alongside a reduced-calorie diet and increased physical activity, for chronic weight management in adults with obesity, or with overweight and at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. Foundayo is not currently approved as a treatment for type 2 diabetes on its own, and it is not intended for cosmetic or short-term weight loss unrelated to a broader weight-management plan.

• Active ingredient: orforglipron, a non-peptide (small-molecule) GLP-1 receptor agonist
• Form: film-coated tablet, taken once daily by mouth
• Available strengths: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg (30 tablets per pack)
• Typical step-up schedule: start at 0.8 mg for at least 30 days, then 2.5 mg for at least 30 days, then 5.5 mg; further increases to 9 mg, 14.5 mg, or 17.2 mg happen at least 30 days apart, based on response and tolerability
• Substitution caution: Foundayo is not interchangeable with injectable GLP-1 medications (such as Ozempic, Wegovy, or Zepbound) or with other oral GLP-1 products (such as Rybelsus or Wegovy Pill) — do not switch forms or brands without your clinician’s direction

Foundayo tablets are light-sensitive. Keep them in their original container with the desiccant included, tightly closed, and away from direct light, heat, and moisture. Store at room temperature and keep out of reach of children, using the child-resistant closure provided. Dispose of any unused tablets through a pharmacy take-back program rather than household trash.

Common Foundayo side effects include nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, headache, tiredness, dizziness, bloating, belching, gas, and hair loss. These tend to be more noticeable during dose increases.

Serious warning signs that need prompt medical attention include severe or persistent abdominal pain (possible pancreatitis), signs of gallbladder problems, signs of an allergic reaction such as swelling or trouble breathing, new or worsening depression or suicidal thoughts, and signs of dehydration or worsening kidney function.